Anesthesia modality in endovascular treatment for distal medium vessel occlusion stroke: intention-to-treat propensity score-matched analysis.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mohammaden Mahmoud H, Doheim Mohamed F, Abdelhamid Hend, Matsoukas Stavros, Schuldt Braxton Riley, Fifi Johanna T, Kuybu Okkes, Gross Bradley A, Al-Bayati Alhamza R, Dolia Jaydevsinh, Grossberg Jonathan A, Olive-Gadea Marta, Rodrigo-Gisbert Marc, Requena Manuel, Monteiro Andre, Yu Siyuan, Siegler James E, Rodriguez-Calienes Aaron, Galecio-Castillo Milagros, Ortega-Gutierrez Santiago, Cortez Gustavo M, Hanel Ricardo A, Aghaebrahim Amin, Hassan Ameer E, Nguyen Thanh N, Abdalkader Mohamad, Klein Piers, Salem Mohamed M, Burkhardt Jan-Karl, Jankowitz Brian T, Colasurdo Marco, Kan Peter, Hafeez Muhammad, Tanweer Omar, Peng Sophia, Alaraj Ali, Siddiqui Adnan H, Nogueira Raul G, Haussen Diogo C
Аннотация
METHODS: This is a multicenter retrospective analysis of a prospectively collected database. Patients were included if they had DMVO involving the middle cerebral artery-M3/4, anterior cerebral artery-A2/3, or posterior cerebral artery-P1/P2-3, and underwent EVT. The cohort was divided into two groups, general anesthesia (GA) and non-general anesthesia (non-GA), and compared based on the intention-to-treat principle as primary analysis. We used propensity scores to balance the two groups. The primary outcome was the shift in the degree of disability as measured by the 90-day modified Rankin Scale (mRS). Secondary outcomes included successful reperfusion, as well as excellent (mRS 0-1) and good (mRS 0-2) clinical outcomes at 90 days. Safety measures included procedural complications, symptomatic intracerebral hemorrhage (sICH), and 90-day mortality.
RESULTS: Among 366 DMVO thrombectomies, 61 matched pairs were eligible for analysis. Median age and National Institutes of Health Stroke Scale score as well as other baseline demographic and clinical characteristics were balanced between both groups. The GA group had no difference in the overall degree of disability (common OR 1.19, 95% CI 0.52 to 2.86, P=0.67) compared with the non-GA arm. Likewise, the GA group had comparable rates of successful reperfusion (OR 2.38, 95% CI 0.80 to 7.07, P=0.12), good/excellent clinical outcomes (OR 1.14, 95% CI 0.44 to 2.96, P=0.79/(OR 0.65, 95% CI 0.24 to 1.81, P=0.41), procedural complications (OR 1.00, 95% CI 0.19 to 5.16, P>0.99), sICH (OR 3.24, 95% CI 0.83 to 12.68, P=0.09), and 90-day mortality (OR 1.43, 95% CI 0.48 to 4.27, P=0.52) compared with the non-GA group.
CONCLUSIONS: In patients with DMVO, our study showed that GA and non-GA groups had similar procedural and clinical outcomes, as well as safety measures. Further larger controlled studies are warranted.